Antihypertensive medication prescription dispensation among pregnant women in the United States: A cohort study

IF 3.7 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS
Melanie T. Chen MD, MPH , Brandi L. Vollmer MPH, PhD , C. Adair Blyler PharmD , Natalie A. Cameron MD, MPH , Eliza C. Miller MD, MS , Yongmei Huang MD, DrPH , Alexander M. Friedman MD , Jason D. Wright MD , Amelia K. Boehme MSPH, PhD , Natalie A. Bello MD, MPH
{"title":"Antihypertensive medication prescription dispensation among pregnant women in the United States: A cohort study","authors":"Melanie T. Chen MD, MPH ,&nbsp;Brandi L. Vollmer MPH, PhD ,&nbsp;C. Adair Blyler PharmD ,&nbsp;Natalie A. Cameron MD, MPH ,&nbsp;Eliza C. Miller MD, MS ,&nbsp;Yongmei Huang MD, DrPH ,&nbsp;Alexander M. Friedman MD ,&nbsp;Jason D. Wright MD ,&nbsp;Amelia K. Boehme MSPH, PhD ,&nbsp;Natalie A. Bello MD, MPH","doi":"10.1016/j.ahj.2024.08.010","DOIUrl":null,"url":null,"abstract":"<div><h3>Importance</h3><p>Hypertension is increasingly common in pregnancy capable individuals, yet there is limited data on antihypertensive medication dispensation in peripartum individuals.</p></div><div><h3>Objective</h3><p>To describe antihypertensive medication dispensation from preconception through the first year postpartum.</p></div><div><h3>Design, Setting, and Participants</h3><p>This retrospective cohort study used the Truven Health Market Scan administrative data from 2008 to 2014 to identify women in the United States with commercial or government health insurance, aged 15-54, free from heart disease, who experienced a pregnancy and filled at least 1 prescription for an antihypertensive medication between 3 months prior to conception and 12 months after the end of the pregnancy.</p></div><div><h3>Main Outcomes and Measures</h3><p>We describe antihypertensive dispensation patterns (continuation, initiation, and discontinuation) by medication class during 5 time periods: preconception, first, second, and third trimesters, and the first year postpartum.</p></div><div><h3>Results</h3><p>Of 1,058,521 pregnancies, 108,614 (10.3%) were exposed to at least 1 antihypertensive medication dispensation. The most commonly dispensed medications across all periods combined were adrenergic blockers, calcium channel blockers (CCBs), and diuretics. Renin-angiotensin-aldosterone system (RAAS) inhibitors were the third most dispensed medication class in the preconception period (26.4%), and fills decreased to 5.7% and 1.7% in the second and third trimesters, respectively. Of the women with chronic hypertension who filled at least 1 prescription prior to conception, 8.4% were not dispensed an antihypertensive medication during the first year after delivery.</p></div><div><h3>Conclusions and Relevance</h3><p>Antihypertensive prescription dispensation of both preferred and potentially harmful agents is common in pregnancy capable individuals. Patterns of dispensation suggest room for improvement in the treatment of chronic hypertension after a pregnancy.</p></div>","PeriodicalId":7868,"journal":{"name":"American heart journal","volume":"278 ","pages":"Pages 5-13"},"PeriodicalIF":3.7000,"publicationDate":"2024-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American heart journal","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0002870324002059","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Importance

Hypertension is increasingly common in pregnancy capable individuals, yet there is limited data on antihypertensive medication dispensation in peripartum individuals.

Objective

To describe antihypertensive medication dispensation from preconception through the first year postpartum.

Design, Setting, and Participants

This retrospective cohort study used the Truven Health Market Scan administrative data from 2008 to 2014 to identify women in the United States with commercial or government health insurance, aged 15-54, free from heart disease, who experienced a pregnancy and filled at least 1 prescription for an antihypertensive medication between 3 months prior to conception and 12 months after the end of the pregnancy.

Main Outcomes and Measures

We describe antihypertensive dispensation patterns (continuation, initiation, and discontinuation) by medication class during 5 time periods: preconception, first, second, and third trimesters, and the first year postpartum.

Results

Of 1,058,521 pregnancies, 108,614 (10.3%) were exposed to at least 1 antihypertensive medication dispensation. The most commonly dispensed medications across all periods combined were adrenergic blockers, calcium channel blockers (CCBs), and diuretics. Renin-angiotensin-aldosterone system (RAAS) inhibitors were the third most dispensed medication class in the preconception period (26.4%), and fills decreased to 5.7% and 1.7% in the second and third trimesters, respectively. Of the women with chronic hypertension who filled at least 1 prescription prior to conception, 8.4% were not dispensed an antihypertensive medication during the first year after delivery.

Conclusions and Relevance

Antihypertensive prescription dispensation of both preferred and potentially harmful agents is common in pregnancy capable individuals. Patterns of dispensation suggest room for improvement in the treatment of chronic hypertension after a pregnancy.

美国孕妇的抗高血压药物处方分配:一项队列研究。
重要性:高血压在能够怀孕的人群中越来越常见,但有关围产期人群降压药物分配的数据却很有限:目的:描述从孕前到产后第一年的降压药配药情况:这项回顾性队列研究使用了 2008 年至 2014 年的 Truven Health MarketScan 管理数据,以识别美国拥有商业或政府医疗保险、年龄在 15-54 岁之间、无心脏病、经历过妊娠并在受孕前三个月至妊娠结束后 12 个月期间至少开过一次降压药处方的女性:我们按药物类别描述了孕前、孕期第一、第二和第三季度以及产后第一年五个时间段内的降压药配药模式(继续用药、开始用药和停药):在 1,058,521 例妊娠中,108,614 例(10.3%)至少接受过一次降压药物治疗。在所有时期中,最常配发的药物是肾上腺素能阻滞剂、钙通道阻滞剂(CCB)和利尿剂。肾素-血管紧张素-醛固酮系统(RAAS)抑制剂是孕前配药率第三高的药物类别(26.4%),在孕中期和孕晚期的配药率分别降至 5.7% 和 1.7%。在孕前至少开过一次处方的慢性高血压妇女中,有 8.4% 的人在产后第一年内没有配过降压药:妊娠期高血压患者的降压药处方中,既有首选药物,也有可能有害的药物。配药模式表明,妊娠后慢性高血压的治疗仍有改进的余地。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
American heart journal
American heart journal 医学-心血管系统
CiteScore
8.20
自引率
2.10%
发文量
214
审稿时长
38 days
期刊介绍: The American Heart Journal will consider for publication suitable articles on topics pertaining to the broad discipline of cardiovascular disease. Our goal is to provide the reader primary investigation, scholarly review, and opinion concerning the practice of cardiovascular medicine. We especially encourage submission of 3 types of reports that are not frequently seen in cardiovascular journals: negative clinical studies, reports on study designs, and studies involving the organization of medical care. The Journal does not accept individual case reports or original articles involving bench laboratory or animal research.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信